D
Regeneron Pharmaceuticals, Inc. REGN
$527.78 -$19.89-3.63% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments 8.35B 9.01B 9.80B 9.81B 10.52B
Total Receivables 5.56B 6.21B 6.11B 5.72B 5.22B
Inventory 3.19B 3.09B 3.02B 2.87B 2.71B
Prepaid Expenses 468.90M 348.40M 412.00M 674.40M 414.90M
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- 800.00K -- 7.50M --
Total Current Assets 17.57B 18.66B 19.33B 19.08B 18.87B

Total Current Assets 17.57B 18.66B 19.33B 19.08B 18.87B
Net Property, Plant & Equipment 4.69B 4.82B 4.44B 4.31B 4.23B
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles 1.17B 1.15B 1.12B 1.10B 1.06B
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 4.52B 4.07B 3.90B 3.68B 3.16B
Total Assets 37.55B 37.76B 37.44B 36.09B 34.37B

Total Accounts Payable 705.50M 789.50M 497.30M 561.70M 671.30M
Total Accrued Expenses 2.24B 2.50B 2.54B 2.36B 2.39B
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- 30.30M -- -- --
Total Finance Division Other Current Liabilities 619.30M 627.70M 627.20M 586.00M 516.70M
Total Other Current Liabilities 619.30M 627.70M 627.20M 586.00M 516.70M
Total Current Liabilities 3.57B 3.94B 3.66B 3.51B 3.58B

Total Current Liabilities 3.57B 3.94B 3.66B 3.51B 3.58B
Long-Term Debt 1.98B 1.98B 1.98B 1.98B 1.98B
Short-term Debt -- -- -- -- --
Capital Leases 720.00M 924.10M 720.00M 720.00M 720.00M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 1.89B 1.55B 1.75B 1.67B 1.09B
Total Liabilities 8.16B 8.41B 8.12B 7.88B 7.38B

Common Stock & APIC 13.19B 12.86B 12.70B 12.32B 11.94B
Retained Earnings 32.38B 31.67B 30.76B 29.41B 27.98B
Treasury Stock & Other -16.19B -15.18B -14.13B -13.53B -12.93B
Total Common Equity 29.39B 29.35B 29.33B 28.21B 26.99B

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 29.39B 29.35B 29.33B 28.21B 26.99B
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 29.39B 29.35B 29.33B 28.21B 26.99B